Employment after therapy for localized prostate cancer: Widening the perspective

Journal of the National Cancer Institute

Volumn 97, Issue 13, 2005, Pages 948-949

  Talcott, James A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER REGISTRY; CANCER SCREENING; CANCER SURVIVAL; DAILY LIFE ACTIVITY; EDITORIAL; EMPLOYMENT; FOLLOW UP; HEALTH PROGRAM; HUMAN; JOB PERFORMANCE; MALE; MALE SEXUAL DYSFUNCTION; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE SURGERY; QUALITY OF LIFE; QUESTIONNAIRE; SYMPTOMATOLOGY; UNEMPLOYMENT; WORK CAPACITY; WORK RESUMPTION; WORKING TIME; NOTE; PATHOLOGY; PROSTATE TUMOR;

EMPLOYMENT; HUMANS; MALE; PROSTATIC NEOPLASMS; UNEMPLOYMENT;

EID: 21244487886     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dji182     Document Type: Editorial

References (15)

1. Holmberg L, Bill-Axelson A, Helgesen F, Salo JO, Folmerz P, Haggman M, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002;347:781-9.
2. Bill-Axelson A, Holmberg L, Ruutu M, Haggman M, Andersson SO, Bratell S, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005;352:1977-84.
3. Gigerenzer G. The psychology of good judgment: Frequency formats and simple algorithms. Med Decis Making 1996;16:273-80.
4. Fowler FJ Jr, Barry MJ, Lu-Yao G, Roman A, Wasson J, Wennberg JE. Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988-1990 (updated June 1993). Urology 1993;42:622-9.
5. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA 1995;273:129-35.
6. Clark JA, Bokhour BG, Inui TS, Silliman RA, Talcott JA. Measuring patients' perceptions of the outcomes of treatment for early prostate cancer. Med Care 2003;41:923-36.
7. Talcott JA, Manola J, Clark JA, Kaplan I, Beard CJ, Mitchell SP, et al. Time course and predictors of symptoms after primary prostate cancer therapy. J Clin Oncol 2003;21:3979-86.
8. Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000;56:899-905.
9. Bradley CJ, Neumark D, Luo Z, Bednarek H, Schenk M. Employment outcomes of men treated for prostate cancer. J Natl Cancer Inst 2005;97: 958-65.
10. Litwin MS, McGuigan KA, Shpall AI, Dhanani N. Recovery of health related quality of life in the year after radical prostatectomy: Early experience. J Urol 1999;161:515-9.
11. Clark JA, Rieker P, Propert KJ, Talcott JA. Changes in quality of life following treatment for early prostate cancer. Urology 1999;53:161-8.
12. Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level
13. Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003;349:215-24.
14. Haynes RB, Sackett DL, Taylor DW, Gibson ES, Johnson AL. Increased absenteeism from work after detection and labeling of hypertensioe patients. N Engl J Med 1978;299:741-4.
15. Taylor DW, Haynes RB, Sackett DL, Gibson ES. Longterm follow-up of absenteeism among working men following the detection and treatment of their hypertension. Clin Invest Med 1981;4:173-7.